Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorM.D. Anderson Cancer Center

About this trial

An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of imaging, treatment, and clinical outcome data to characterize bone marrow features and changes over time

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of a hematologic, oncologic, or other condition relevant to the study.

Availability of clinical, imaging, laboratory, treatment, and/or outcome data relevant to the study.

Ability to provide informed consent for prospective participation or, for pediatric participants, parent/legal guardian permission with assent when applicable.

Participants undergoing research MRI must be eligible for MRI according to institutional safety requirements.

Disqualifiers

Inability to provide required informed consent or parental/legal guardian permission for prospective participation.

Insufficient clinical information to support study participation

Pregnancy.

Contraindication to MRI will exclude participants from research-specific MRI but not necessarily from other study components.

Trial population

UT MD Anderson Cancer Center

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Data Collection

    Other intervention

    Clinical, imaging, laboratory, treatment, and outcome data will be collected from institutional records and research assessments, as applicable.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Bone marrow imaging characteristics.

Evaluation of bone marrow imaging findings and longitudinal changes in patients with hematologic, oncologic, and other relevant conditions.

Time frame
Through study completion; an average of 1 year.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.